School nurses improve public health through vaccine promotion and mandate compliance. Despite recommendations and support for comprehensive adolescent HPV vaccination from organizations like the National Association of School Nurses as of 2023 only Virginia, Washington DC, Rhode Island, and Hawaii mandate HPV vaccine in schools. Virginia's mandate allows caregivers to opt out of vaccination. It is important to consider how school-level vaccine compliance is associated with school and community factors. A multilevel analysis explored the association between school and county-level factors and HPV vaccination rates. This study shows schools that report higher rates of economically disadvantaged students had higher HPV vaccine coverage. HPV vaccine rates increased from 2019 to 2021 after the implementation of a gender-inclusive mandate. Virginia HPV rates still lag behind states with no mandate. The results suggest that school nursing practice related to HPV vaccine compliance may be impacted by community factors like economic status.
AbebeD. S.NielsenV. O.FinnvoldJ. E. (2012). Regional inequality and vaccine uptake: A multilevel analysis of the 2007 welfare monitoring survey in Malawi. BMC Public Health, 12(1), 1075. https://doi.org/10.1186/1471-2458-12-1075
2.
Adjei BoakyeE.NairM.AbouelellaD. K.JosephC. L. M.GerendM. A.SubramaniamD. S.Osazuwa-PetersN. (2023). Trends in reasons for human papillomavirus vaccine hesitancy: 2010–2020. Pediatrics, 151(6), e2022060410. https://doi.org/10.1542/peds.2022-060410
BabalolaS. (2009). Determinants of the uptake of the full dose of Diphtheria–Pertussis–Tetanus vaccines (DPT3) in northern Nigeria: A multilevel analysis. Maternal and Child Health Journal, 13(4), 550–558. https://doi.org/10.1007/s10995-008-0386-5
5.
Bednarczyk, R. A., King, A. R., Lahijani, A., & Omer, S. B. (2019). Current landscape of nonmedical vaccination exemptions in the United States: Impact of policy changes. Expert Review of Vaccines, 18(2), 175–190. https://doi.org/10.1080/14760584.2019.1562344
6.
BozigarM.FaithT. D.WhiteA. A.DraytonK. D.FabickA.CartmellK. B. (2020). A cross-sectional survey to evaluate potential for partnering with school nurses to promote human papillomavirus vaccination. Preventing Chronic Disease, 17(E 111), 190451. https://doi.org/10.5888/pcd17.190451
7.
BrandtH. M.FootmanA.AdsulP.RamanadhanS.KepkaD. (2023). Implementing interventions to start HPV vaccination at age 9: Using the evidence we have. Human Vaccines & Immunotherapeutics, 19(1), 2180250. https://doi.org/10.1080/21645515.2023.2180250
8.
CarhartM. Y.SchminkeyD. L.MitchellE. M.Keim-MalpassJ. (2018). Barriers and facilitators to improving Virginia’s HPV vaccination rate: A stakeholder analysis with implications for pediatric nurses. Journal of Pediatric Nursing, 42, 1–8. https://doi.org/10.1016/j.pedn.2018.05.008
Chen, M. S., & Dang, J. H. (2017). What might we learn from the more successful uptake of Hepatitis B (HBV) vaccinations to increase Human Papillomavirus (HPV) vaccinations in adolescents? Vaccine, 35(31), 3801–3802. https://doi.org/10.1016/j.vaccine.2017.05.078
11.
ColeJ. W.ChenA. M. H.McGuireK.BermanS.GardnerJ.TeegalaY. (2022). Motivational interviewing and vaccine acceptance in children: The MOTIVE study. Vaccine, 40(12), 1846–1854. https://doi.org/10.1016/j.vaccine.2022.01.058
12.
CuffR. D.BuchananT.PelkofskiE.KorteJ.ModesittS. P.PierceJ. Y. (2016). Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia. American Journal of Obstetrics and Gynecology, 214(6), 752.e1–752.e6. https://doi.org/10.1016/j.ajog.2016.03.022
13.
DeSalvoK. B.WangY. C.HarrisA.AuerbachJ.KooD.O’CarrollP. (2017). Public health 3.0: A call to action for public health to meet the challenges of the 21st century. Preventing Chronic Disease, 14(E78), 170017. https://doi.org/10.5888/pcd14.170017
14.
Ebell, M. H. (2021). HPV vaccine, especially before age 17, is associated with a large reduction in invasive cervical cancer. American Family Physician, 103(5), 312–312.
15.
EstepK. A. (2018). Neighborhood political composition and personal belief exemptions from immunization requirements in California Kindergartens, 2000–2015. Vaccine, 36(29), 4298–4303. https://doi.org/10.1016/j.vaccine.2018.05.108
16.
Fisher, H., Chantler, T., Finn, A., Kesten, J., Hickman, M., Letley, L., Mounier-Jack, S., Thomas, C., Worthington, K., Yates, J., & Audrey, S. (2022). Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: A co-production study with young people and key informants. Research Involvement and Engagement, 8(1), 16. https://doi.org/10.1186/s40900-022-00349-7
17.
FrancoeurA. A.LiaoC.-I.CaesarM. A.ChanA.KappD. S.CohenJ. G.SalaniR.ChanJ. K. (2022). The increasing incidence of stage IV cervical cancer in the USA: What factors are related?International Journal of Gynecologic Cancer, 32(9), 1115–1122. https://doi.org/10.1136/ijgc-2022-003728
18.
GeeJ.WeinbaumC.SukumaranL.MarkowitzL. E. (2016). Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States. Human Vaccines & Immunotherapeutics, 12(6), 1406–1417. https://doi.org/10.1080/21645515.2016.1168952
19.
Goldstein, N. D., Suder, J. S., & Purtle, J. (2019). Trends and characteristics of proposed and enacted state legislation on childhood vaccination exemption, 2011–2017. American Journal of Public Health, 109(1), 102–107. https://doi.org/10.2105/AJPH.2018.304765
20.
Hall, M. T., Simms, K. T., Lew, J.-B., Smith, M. A., Brotherton, J. M., Saville, M., Frazer, I. H., & Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: A modelling study. The Lancet Public Health, 4(1), e19–e27. https://doi.org/10.1016/S2468-2667(18)30183-X
21.
JonesK.SubramanianV. S. (2013). Developing multilevel models for analysing contextuality, heterogeneity and change using MLwiN, Volume 2. Unversity of Bristol.
22.
KahnB. Z.HuangQ.ThompsonP.GilkeyM. B.DaileyA.BrewerS.TN. (2023). Getting human papillomavirus vaccination back on track: A national survey. Journal of Adolescent Health, 72(6), 950–957. https://doi.org/10.1016/j.jadohealth.2023.01.004
23.
KajtezovicS.FiasconeS.MorganJ.PerkinsR. (2023). Does bundling matter? The effect of providing HPV vaccination before Tdap vaccination on timely completion of the HPV vaccine series [ID: 1381348]. Obstetrics & Gynecology, 141(5S), 93S–94S. https://doi.org/10.1097/01.AOG.0000931140.49111.7c
Krok-SchoenJ. L.BernardoB. M.WeierR. C.PengJ.KatzM. L.ReiterP. L.RichardsonM. S.PennellM. L.TatumC. M.PaskettE. D. (2018). Belief about mandatory school vaccinations and vaccination refusal among Ohio Appalachian parents: Do demographic and religious factors, general health, and political affiliation play a role?: Ohio Appalachian parental vaccine beliefs/refusal. The Journal of Rural Health, 34(3), 283–292. https://doi.org/10.1111/jrh.12285
26.
LimE.DavisJ.ChoiS. Y.ChenJ. J. (2019). Effect of sociodemographics, health-related problems, and family structure on chronic absenteeism among children. Journal of School Health, 89(4), 308–318. https://doi.org/10.1111/josh.12736
27.
McNeishD.KelleyK. (2019). Fixed effects models versus mixed effects models for clustered data: Reviewing the approaches, disentangling the differences, and making recommendations. Psychological Methods, 24(1), 20–35. https://doi.org/10.1037/met0000182
28.
Mattebo, M., Gottvall, M., & Grandahl, M. (2021). School nurses' perceptions and experiences of delivering a school-based intervention to improve primary prevention of human papillomavirus among adolescents-A focus group study following a randomized controlled trial. The Journal of School Nursing, 40(2), 166–173. https://doi.org/10.1177/10598405211046174
29.
MonsalvesM. J.BangdiwalaA. S.ThabaneA.BangdiwalaS. I. (2020). LEVEL (Logical explanations & visualizations of estimates in linear mixed models): Recommendations for reporting multilevel data and analyses. BMC Medical Research Methodology, 20(1), 3. https://doi.org/10.1186/s12874-019-0876-8
30.
National Association of School Nurses (2020). Framework for 21st century school nursing practiceTM: Clarifications and updated definitions. NASN School Nurse, 35(4), 225–233. https://doi.org/10.1177/1942602X20928372
PaudelY. R.DuC.MacDonaldS. E. (2022). The influence of place on COVID-19 vaccine coverage in Alberta: A multilevel analysis. PLOS ONE, 17(10), e0276160. https://doi.org/10.1371/journal.pone.0276160
34.
Pierre-VictorD.PageT. F.TrepkaM. J.StephensD. P.LiT.MadhivananP. (2017). Impact of Virginia’s school-entry vaccine mandate on human papillomavirus vaccination among 13–17-year-old females. Journal of Women’s Health, 26(3), 266–275. https://doi.org/10.1089/jwh.2016.5869
35.
PingaliC.YankeyD.Elam-EvansL. D.MarkowitzL. E.WilliamsC. L.FreduaB.McNamaraL. A.StokleyS.SingletonJ. A. (2021). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2020. MMWR. Morbidity and Mortality Weekly Report, 70(35), 1183–1190. https://doi.org/10.15585/mmwr.mm7035a1
36.
PingaliC.YankeyD.Elam-EvansL. D.MarkowitzL. E.ValierM. R.FreduaB.CroweS. J.StokleyS.SingletonJ. A. (2022). National vaccination coverage among adolescents aged 13–17 years—national immunization survey-teen, United States, 2021. MMWR. Morbidity and Mortality Weekly Report, 71(35), 1101–1108. https://doi.org/10.15585/mmwr.mm7135a1
37.
PingaliC.YankeyD.Elam-EvansL. D.MarkowitzL. E.ValierM. R.FreduaB.CroweS. J.DeSistoC. L.StokleyS.SingletonJ. A. (2023). Vaccination coverage among adolescents aged 13–17 years—national immunization survey–teen, United States, 2022. MMWR. Morbidity and Mortality Weekly Report, 72(34), 912–919. https://doi.org/10.15585/mmwr.mm7234a3
38.
PolonijoA. N. (2020). The impact of school-entry mandates on social inequalities in human papillomavirus vaccination. SSM - Population Health, 12, 100647. https://doi.org/10.1016/j.ssmph.2020.100647
39.
PortetS. (2020). A primer on model selection using the akaike information criterion. Infectious Disease Modelling, 5, 111–128. https://doi.org/10.1016/j.idm.2019.12.010
40.
PortnoyA.ClarkS.OzawaS.JitM. (2020). The impact of vaccination on gender equity: Conceptual framework and human papillomavirus (HPV) vaccine case study. International Journal for Equity in Health, 19(1), 10. https://doi.org/10.1186/s12939-019-1090-3
41.
RandC. M.ConcannonC.Wallace-BrodeurR.DavisW.AlbertinC. S.HumistonS. G.SzilagyiP. G. (2020). Identifying strategies to reduce missed opportunities for HPV vaccination in primary care: A qualitative study of positive deviants. Clinical Pediatrics, 59(12), 1058–1068. https://doi.org/10.1177/0009922820930357
42.
RichwineC.DorA.MoghtaderiA. (2019). Do stricter immunization laws improve coverage? Evidence from the repeal of non-medical exemptions for school mandated vaccines (w25847; p. w25847). National Bureau of Economic Research. https://doi.org/10.3386/w25847
43.
RobertsM. C.MurphyT.MossJ. L.WheldonC. W.PsekW. (2018). A qualitative comparative analysis of combined state health policies related to human papillomavirus vaccine uptake in the United States. American Journal of Public Health, 108(4), 493–499. https://doi.org/10.2105/AJPH.2017.304263
44.
SanfordC.SaurmanE.DennisS.LyleD. (2021). We’re definitely that link’: The role of school-based primary health care registered nurses in a rural community. Australian Journal of Primary Health, 27(2), 76. https://doi.org/10.1071/PY20149
StaplesJ. N.NelamangalaS. L.MorrisS.WellsK. (2021). Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia. Vaccine, 39(38), 5385–5390. https://doi.org/10.1016/j.vaccine.2021.07.079
47.
Strategic Advisory Group of Experts on Immunization. (2022). Understanding the behavioural and social drivers of vaccine uptake WHO position paper (Weekly Epidemiological Record, 2022, vols. 97, 20). World Health Organization. https://www.who.int/publications/i/item/who-wer9720-209-224
48.
SuryadevaraM.BonvilleC. A.CibulaD. A.DomachowskeJ. B.SuryadevaraA. C. (2019). Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates. Vaccine, 37(9), 1160–1167. https://doi.org/10.1016/j.vaccine.2019.01.036
WheelerD. C.MillerC. A.DoE. K.KsinanA. J.TrogdonJ. G.ChukmaitovA.FuemmelerB. F. (2021). Identifying area-level disparities in human papillomavirus vaccination coverage using geospatial analysis. Cancer Epidemiology, Biomarkers & Prevention, 30(9), 1689–1696. https://doi.org/10.1158/1055-9965.EPI-21-0331
53.
WilsonO. F.MoteS. L.MorseB. L. (2023). Addressing vaccine hesitancy among students and families: Interventions for school nurses. NASN School Nurse, 38(3), 146–154. https://doi.org/10.1177/1942602X221106945
54.
YooW.KoskanA.ScotchM.PottingerH.HuhW. K.HelitzerD. (2020). Patterns and disparities in human papillomavirus (HPV) vaccine uptake for young female adolescents among U.S. States: NIS-teen (2008–2016). Cancer Epidemiology, Biomarkers & Prevention, 29(7), 1458–1467. https://doi.org/10.1158/1055-9965.EPI-19-1103
55.
ZhuY.WuC.-F.GiulianoA. R.FernandezM. E.OrtizA. P.CazabanC. G.LiR.DeshmukhA. A.SonawaneK. (2022). Tdap-HPV vaccination bundling in the USA: Trends, predictors, and implications for vaccine series completion. Preventive Medicine, 164, 107218. https://doi.org/10.1016/j.ypmed.2022.107218
